WILLIAM STRAHAN: Open Payments
NPI 1619379831 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 34 payments from 10 companies in 2025. Trend: 2023 $1,148 · 2024 $901 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $310 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Novo Nordisk Inc | 3 | $52 |
| Corium, LLC | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
| Abbott Laboratories | 1 | $33 |
| Lundbeck LLC | 1 | $23 |
| TOLMAR, INC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: QULIPTA, VRAYLAR, UBRELVY, Auvelity, AIRSUPRA, Azstarys, FANAPT, FREESTYLE LIBRE 3.
Industry payments across LA — which companies pay providers there.
